GE stock gets upgrade from Oppenheimer, price target raised to $104
Analysts at Oppenheimer on Tuesday upgraded their rating on General Electric Co. stock to the equivalent of buy, reflecting "strong" momentum for its aviation business, "consistent and broad-based profitability" for its power business, and the fact that the health-care unit is on track for a spinoff. The analysts also raised their price target on the stock to $104, representing an upside of around 22% from Tuesday prices. GE last week said its board officially approved the GE HealthCare spinoff, with the unit becoming a corporation to be named GE HealthCare Technologies Inc. The company is expected to begin trading on the Nasdaq on Jan. 4. Shares of GE have lost about 11% so far this year, compared with losses of around 17% for the S&P 500 index.
-Claudia Assis
(END) Dow Jones Newswires
December 06, 2022 12:29 ET (17:29 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.